Detection of specifically oxidized apolipoproteins in oxidized HDL

Methods in Molecular Biology

Volumn 477, Issue , 2008, Pages 49-63

  Wang, Xiao Suo ^a   Stocker, Roland ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antioxidants; HPLC; Lipid peroxidation; LOOH; MetO; Oxidized apolipoproteins; Oxidized HDL; Ultracentrifugation

Indexed keywords

2,2' AZOBIS(2 AMIDINOPROPANE); 2,2'-AZOBIS(2-AMIDINOPROPANE); AMIDINE; APOLIPOPROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CHEMISTRY; DRUG EFFECT; GENETICS; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METHODOLOGY; OXIDATION REDUCTION REACTION; REPRODUCIBILITY; TIME;

AMIDINES; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS; CHEMISTRY, ANALYTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENOTYPE; HUMANS; LIPOPROTEINS, HDL; MASS SPECTROMETRY; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 58149401587     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-517-0_5     Document Type: Article

References (20)

1. Stocker R, Keaney JF, Jr (2004) Role of oxidative modifications in atherosclerosis. Physiol Rev 84, 1381-1478.
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL (1989) Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320, 915-924.
3. Bowry VW, Stanley KK, Stocker R (1992) High density lipoprotein is the major carrier of lipid hydroperoxides in fasted human plasma. Proc Natl Acad Sci USA 89, 10316-10320.
4. Niu X, Zammit V, Upston JM, Dean RT, Stocker R (1999) Co-existence of oxidized lipids and α-tocopherol in all lipoprotein fractions isolated from advanced human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 19, 1708-1718.
5. Zheng L, Nukuna B, Brennan ML, et al. (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114, 529-541.
6. Bergt C, Pennathur S, Fu X, et al. (2004) The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci USA 101, 13032-13037.
7. Peng DQ, Wu Z, Brubaker G, et al. (2005) Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities. J Biol Chem 280, 33775-33784.
8. Oram JF, Heinecke JW (2005) ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 85, 1343-1372.
9. Shao B, Oda MN, Bergt C, et al. (2006) Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J Biol Chem 14, 9001-9004.
10. Panzenböck U, Kritharides L, Raftery M, Rye KA, Stocker R (2000) Oxidation of methionine residues to methionine sulfoxides does not decrease potential anti-atherogenic properties of apolipoprotein A-I. J Biol Chem 275, 19536-19544.
11. Francis GA, Oram JF, Heinecke JW, Bierman EL (1996) Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry 35, 15188-15197.
12. Pankhurst G, Wang XL, Wilcken DE, et al. (2003) Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein. J Lipid Res 44, 349-355.
13. Pennathur S, Bergt C, Shao B, et al. (2004) Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem 279, 42977-42983.
14. Hazell LJ, Davies MJ, Stocker R (1999) Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins. Biochem J 339, 489-495.
15. Sattler W, Christison JK, Stocker R (1995) Cholesterylester hydroperoxide reducing activity associated with isolated high- and low-density lipoproteins. Free Radic Biol Med 18, 421-429.
16. Mashima R, Yamamoto Y, Yoshimura S (1998) Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of the hydroperoxide-reducing proteins from human blood plasma. J Lipid Res 39, 1133-1140.
17. Garner B, Witting PK, Waldeck AR, Christison JK, Raftery M, Stocker R (1998) Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that correlates with lipid peroxidation and can be enhanced by α-tocopherol. J Biol Chem 273, 6080-6087.
18. Garner B, Waldeck AR, Witting PK, Rye K-A, Stocker R (1998) Oxidation of high density lipoproteins. II. Evidence for direct reduction of HDL lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem 273, 6088-6095.
19. Barclay LRC, Locke SJ, MacNeil JM, VanKessel J (1984) Autoxidation of micelles and model membranes. Quantitative kinetic measurements can be made by using either water-soluble or lipid-soluble initiators with water-soluble or lipid-soluble chain-breaking antioxidants. J Am Chem Soc 106, 2479- 2481.
20. MacMahon S, Norton R, Jackson R, et al. (1995) Fletcher Challenge-University of Auckland Heart & Health Study: design and baseline findings. N Z Med J 108, 499-502.